Cargando…
A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
Neurofilament light chain (NfL), is a neuron-specific cytoskeletal protein detected in extracellular fluid following axonal damage. Extensive research has focused on NfL quantification in CSF, establishing it as a prognostic biomarker of disability progression in Multiple Sclerosis (MS). Our study u...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341477/ https://www.ncbi.nlm.nih.gov/pubmed/37445963 http://dx.doi.org/10.3390/ijms241310787 |
_version_ | 1785072271312814080 |
---|---|
author | Pafiti, Anna Krashias, George Tzartos, John Tzartos, Socrates Stergiou, Christos Gaglia, Eftychia Smoleski, Irene Christodoulou, Christina Pantzaris, Marios Lambrianides, Anastasia |
author_facet | Pafiti, Anna Krashias, George Tzartos, John Tzartos, Socrates Stergiou, Christos Gaglia, Eftychia Smoleski, Irene Christodoulou, Christina Pantzaris, Marios Lambrianides, Anastasia |
author_sort | Pafiti, Anna |
collection | PubMed |
description | Neurofilament light chain (NfL), is a neuron-specific cytoskeletal protein detected in extracellular fluid following axonal damage. Extensive research has focused on NfL quantification in CSF, establishing it as a prognostic biomarker of disability progression in Multiple Sclerosis (MS). Our study used a new commercially available Enzyme-Linked Immunosorbent Assay (ELISA) kit and Single Molecular Array (Simoa) advanced technology to assess serum NfL levels in MS patients and Healthy Controls (HC). Verifying the most accurate, cost-effective methodology will benefit its application in clinical settings. Blood samples were collected from 54 MS patients and 30 HC. Protocols accompanying the kits were followed. The ELISA thershold was set as 3 S.D. above the mean of the HC. For Simoa, the Z-score calculation created by Jens Kuhle’s group was applied (with permission). Samples exceeding the threshold or z-score ≥1.5 indicated subclinical disease activity. To our knowledge, this is the first study to find strong-positive correlation between ELISA and Simoa for the quantification of NfL in serum (r = 0.919). Despite the strong correlation, Simoa has better analytical sensitivity and can detect small changes in samples making it valuable in clinical settings. Further research is required to evaluate whether serum NfL quantification using ELISA could be utilized to predict disability progression. |
format | Online Article Text |
id | pubmed-10341477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103414772023-07-14 A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis Pafiti, Anna Krashias, George Tzartos, John Tzartos, Socrates Stergiou, Christos Gaglia, Eftychia Smoleski, Irene Christodoulou, Christina Pantzaris, Marios Lambrianides, Anastasia Int J Mol Sci Article Neurofilament light chain (NfL), is a neuron-specific cytoskeletal protein detected in extracellular fluid following axonal damage. Extensive research has focused on NfL quantification in CSF, establishing it as a prognostic biomarker of disability progression in Multiple Sclerosis (MS). Our study used a new commercially available Enzyme-Linked Immunosorbent Assay (ELISA) kit and Single Molecular Array (Simoa) advanced technology to assess serum NfL levels in MS patients and Healthy Controls (HC). Verifying the most accurate, cost-effective methodology will benefit its application in clinical settings. Blood samples were collected from 54 MS patients and 30 HC. Protocols accompanying the kits were followed. The ELISA thershold was set as 3 S.D. above the mean of the HC. For Simoa, the Z-score calculation created by Jens Kuhle’s group was applied (with permission). Samples exceeding the threshold or z-score ≥1.5 indicated subclinical disease activity. To our knowledge, this is the first study to find strong-positive correlation between ELISA and Simoa for the quantification of NfL in serum (r = 0.919). Despite the strong correlation, Simoa has better analytical sensitivity and can detect small changes in samples making it valuable in clinical settings. Further research is required to evaluate whether serum NfL quantification using ELISA could be utilized to predict disability progression. MDPI 2023-06-28 /pmc/articles/PMC10341477/ /pubmed/37445963 http://dx.doi.org/10.3390/ijms241310787 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pafiti, Anna Krashias, George Tzartos, John Tzartos, Socrates Stergiou, Christos Gaglia, Eftychia Smoleski, Irene Christodoulou, Christina Pantzaris, Marios Lambrianides, Anastasia A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title | A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title_full | A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title_fullStr | A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title_full_unstemmed | A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title_short | A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis |
title_sort | comparison of two analytical approaches for the quantification of neurofilament light chain, a biomarker of axonal damage in multiple sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341477/ https://www.ncbi.nlm.nih.gov/pubmed/37445963 http://dx.doi.org/10.3390/ijms241310787 |
work_keys_str_mv | AT pafitianna acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT krashiasgeorge acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT tzartosjohn acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT tzartossocrates acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT stergiouchristos acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT gagliaeftychia acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT smoleskiirene acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT christodoulouchristina acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT pantzarismarios acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT lambrianidesanastasia acomparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT pafitianna comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT krashiasgeorge comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT tzartosjohn comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT tzartossocrates comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT stergiouchristos comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT gagliaeftychia comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT smoleskiirene comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT christodoulouchristina comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT pantzarismarios comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis AT lambrianidesanastasia comparisonoftwoanalyticalapproachesforthequantificationofneurofilamentlightchainabiomarkerofaxonaldamageinmultiplesclerosis |